SCORE

NAN

ABUS: Arbutus Biopharma is a Buy

AAPL chart by TradingView

The current rating for ABUS is NAN, which is -100% above its historic median rating of 50. This indicates lower risk than normal.

The rating is currently showing a higher than normal reading, suggesting risk levels could be lower than normal.